Recall
FDAHealthDecember 12, 2025

Merck Sharp & Dohme LLC — Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA,

⚠️ Presence of particulate matter: potential presence of metal particulates in the product.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
December 12, 2025

Nationwide in the USA

What's affected?

Product
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
Brand
NOXAFIL
UPC
0300854324025
Lot code
Z012339

Additional details

Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 845 kits.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.